mefloquine has been researched along with glycerophosphoinositol 4,5-bisphosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aréchiga-Figueroa, IA; Ferrer, T; López-Izquierdo, A; Moreno-Galindo, EG; Ponce-Balbuena, D; Rodríguez-Martínez, M; Rodríguez-Menchaca, AA; Sánchez-Chapula, JA | 1 |
1 other study(ies) available for mefloquine and glycerophosphoinositol 4,5-bisphosphate
Article | Year |
---|---|
The antimalarial drug mefloquine inhibits cardiac inward rectifier K+ channels: evidence for interference in PIP2-channel interaction.
Topics: Animals; Antimalarials; Cats; HEK293 Cells; Humans; Inhibitory Concentration 50; KATP Channels; Mefloquine; Myocytes, Cardiac; Patch-Clamp Techniques; Phosphatidylinositol 4,5-Diphosphate; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying | 2011 |